Rational design of yolk-shell nanostructures for drug delivery

Yolk-shell nanoparticles (YSNPs) are a new class of hollow nanostructures, and their unique properties can be utilized in drug delivery systems. The recent progress in YSNPs-based carriers is highlighted in drug delivery systems. Doxorubicin hydrochloride, ceftriaxone sodium, and methotrexate are th...

Full description

Saved in:
Bibliographic Details
Published in:RSC advances 2020-08, Vol.1 (5), p.394-319
Main Authors: Mohammadi Ziarani, Ghodsi, Mofatehnia, Parisa, Mohajer, Fatemeh, Badiei, Alireza
Format: Article
Language:English
Subjects:
Chemical Sciences
Chemistry
Doxorubicin
Drug delivery systems
Methotrexate
Nanoparticles
Nanostructure
Toxicity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3
cites cdi_FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3
container_end_page 319
container_issue 5
container_start_page 394
container_title RSC advances
container_volume 1
creator Mohammadi Ziarani, Ghodsi
Mofatehnia, Parisa
Mohajer, Fatemeh
Badiei, Alireza
description Yolk-shell nanoparticles (YSNPs) are a new class of hollow nanostructures, and their unique properties can be utilized in drug delivery systems. The recent progress in YSNPs-based carriers is highlighted in drug delivery systems. Doxorubicin hydrochloride, ceftriaxone sodium, and methotrexate are three of the most common drugs that are used in this field. According to the reported studies, the materials used most often as yolk-shells are magnetic nanoparticles and polymers. The used methods for synthesizing a diverse array of YSNPs are classified based on their core structures. Various properties of YSNPs include their high drug-loading capacity, and their ability to decrease drug toxicity and satisfactorily and efficiently release drugs. The recent progress in yolk-shell nanoparticles (YSNPs) as a new class of hollow nanostructures applied for drug delivery.
doi_str_mv 10.1039/d0ra03611k
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2661081683</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2435130393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3</originalsourceid><addsrcrecordid>eNp9ks1PwjAYxhujUYJcvGtmvKjJtG-7lu1CQvADI4kJ0XNTug4mY8V2I-G_twgierCXNn1-ffr2fYrQCeAbwDS5TbGVmHKA6R5qEBzxkGCe7O-sj1DLuXfsB2dAOByiI8oYxIRCA3WGsspNKYsg1S4fl4HJgqUppqGb6KIISlkaV9laVbXVLsiMDVJbjz1c5Attl8foIJOF063N3ERvD_evvX44eHl86nUHoWIsqkKqMMc6JRIYBSk5I74UOWon7TiDWCvgVGsCkYQ4kwnxXByBUjFLWTvSOKNN1Fn7zuvRTKdKl5WVhZjbfCbtUhiZi99KmU_E2CxEglkCEfUGV2uDyZ9j_e5ArPYwZTyhSbQAz15uLrPmo9auErPcKd8OWWpTO0E4BxwDj1e2F3_Qd1Nb305PRZQB9RGtqOs1paxxzupsWwFgsUpR3OFh9yvFZw-f7T51i35n5oHTNWCd2qo_38Dr5__pYp5m9BOMN6su</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435130393</pqid></control><display><type>article</type><title>Rational design of yolk-shell nanostructures for drug delivery</title><source>PubMed Central</source><creator>Mohammadi Ziarani, Ghodsi ; Mofatehnia, Parisa ; Mohajer, Fatemeh ; Badiei, Alireza</creator><creatorcontrib>Mohammadi Ziarani, Ghodsi ; Mofatehnia, Parisa ; Mohajer, Fatemeh ; Badiei, Alireza</creatorcontrib><description>Yolk-shell nanoparticles (YSNPs) are a new class of hollow nanostructures, and their unique properties can be utilized in drug delivery systems. The recent progress in YSNPs-based carriers is highlighted in drug delivery systems. Doxorubicin hydrochloride, ceftriaxone sodium, and methotrexate are three of the most common drugs that are used in this field. According to the reported studies, the materials used most often as yolk-shells are magnetic nanoparticles and polymers. The used methods for synthesizing a diverse array of YSNPs are classified based on their core structures. Various properties of YSNPs include their high drug-loading capacity, and their ability to decrease drug toxicity and satisfactorily and efficiently release drugs. The recent progress in yolk-shell nanoparticles (YSNPs) as a new class of hollow nanostructures applied for drug delivery.</description><identifier>ISSN: 2046-2069</identifier><identifier>EISSN: 2046-2069</identifier><identifier>DOI: 10.1039/d0ra03611k</identifier><identifier>PMID: 35518231</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Chemical Sciences ; Chemistry ; Doxorubicin ; Drug delivery systems ; Methotrexate ; Nanoparticles ; Nanostructure ; Toxicity</subject><ispartof>RSC advances, 2020-08, Vol.1 (5), p.394-319</ispartof><rights>This journal is © The Royal Society of Chemistry.</rights><rights>Copyright Royal Society of Chemistry 2020</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>This journal is © The Royal Society of Chemistry 2020 The Royal Society of Chemistry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3</citedby><cites>FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3</cites><orcidid>0000-0001-5177-7889 ; 0000-0003-0587-2230 ; 0000-0002-6985-7497</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059143/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059143/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35518231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03569394$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohammadi Ziarani, Ghodsi</creatorcontrib><creatorcontrib>Mofatehnia, Parisa</creatorcontrib><creatorcontrib>Mohajer, Fatemeh</creatorcontrib><creatorcontrib>Badiei, Alireza</creatorcontrib><title>Rational design of yolk-shell nanostructures for drug delivery</title><title>RSC advances</title><addtitle>RSC Adv</addtitle><description>Yolk-shell nanoparticles (YSNPs) are a new class of hollow nanostructures, and their unique properties can be utilized in drug delivery systems. The recent progress in YSNPs-based carriers is highlighted in drug delivery systems. Doxorubicin hydrochloride, ceftriaxone sodium, and methotrexate are three of the most common drugs that are used in this field. According to the reported studies, the materials used most often as yolk-shells are magnetic nanoparticles and polymers. The used methods for synthesizing a diverse array of YSNPs are classified based on their core structures. Various properties of YSNPs include their high drug-loading capacity, and their ability to decrease drug toxicity and satisfactorily and efficiently release drugs. The recent progress in yolk-shell nanoparticles (YSNPs) as a new class of hollow nanostructures applied for drug delivery.</description><subject>Chemical Sciences</subject><subject>Chemistry</subject><subject>Doxorubicin</subject><subject>Drug delivery systems</subject><subject>Methotrexate</subject><subject>Nanoparticles</subject><subject>Nanostructure</subject><subject>Toxicity</subject><issn>2046-2069</issn><issn>2046-2069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9ks1PwjAYxhujUYJcvGtmvKjJtG-7lu1CQvADI4kJ0XNTug4mY8V2I-G_twgierCXNn1-ffr2fYrQCeAbwDS5TbGVmHKA6R5qEBzxkGCe7O-sj1DLuXfsB2dAOByiI8oYxIRCA3WGsspNKYsg1S4fl4HJgqUppqGb6KIISlkaV9laVbXVLsiMDVJbjz1c5Attl8foIJOF063N3ERvD_evvX44eHl86nUHoWIsqkKqMMc6JRIYBSk5I74UOWon7TiDWCvgVGsCkYQ4kwnxXByBUjFLWTvSOKNN1Fn7zuvRTKdKl5WVhZjbfCbtUhiZi99KmU_E2CxEglkCEfUGV2uDyZ9j_e5ArPYwZTyhSbQAz15uLrPmo9auErPcKd8OWWpTO0E4BxwDj1e2F3_Qd1Nb305PRZQB9RGtqOs1paxxzupsWwFgsUpR3OFh9yvFZw-f7T51i35n5oHTNWCd2qo_38Dr5__pYp5m9BOMN6su</recordid><startdate>20200814</startdate><enddate>20200814</enddate><creator>Mohammadi Ziarani, Ghodsi</creator><creator>Mofatehnia, Parisa</creator><creator>Mohajer, Fatemeh</creator><creator>Badiei, Alireza</creator><general>Royal Society of Chemistry</general><general>The Royal Society of Chemistry</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SR</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5177-7889</orcidid><orcidid>https://orcid.org/0000-0003-0587-2230</orcidid><orcidid>https://orcid.org/0000-0002-6985-7497</orcidid></search><sort><creationdate>20200814</creationdate><title>Rational design of yolk-shell nanostructures for drug delivery</title><author>Mohammadi Ziarani, Ghodsi ; Mofatehnia, Parisa ; Mohajer, Fatemeh ; Badiei, Alireza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Chemical Sciences</topic><topic>Chemistry</topic><topic>Doxorubicin</topic><topic>Drug delivery systems</topic><topic>Methotrexate</topic><topic>Nanoparticles</topic><topic>Nanostructure</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohammadi Ziarani, Ghodsi</creatorcontrib><creatorcontrib>Mofatehnia, Parisa</creatorcontrib><creatorcontrib>Mohajer, Fatemeh</creatorcontrib><creatorcontrib>Badiei, Alireza</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Engineered Materials Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>RSC advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohammadi Ziarani, Ghodsi</au><au>Mofatehnia, Parisa</au><au>Mohajer, Fatemeh</au><au>Badiei, Alireza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rational design of yolk-shell nanostructures for drug delivery</atitle><jtitle>RSC advances</jtitle><addtitle>RSC Adv</addtitle><date>2020-08-14</date><risdate>2020</risdate><volume>1</volume><issue>5</issue><spage>394</spage><epage>319</epage><pages>394-319</pages><issn>2046-2069</issn><eissn>2046-2069</eissn><abstract>Yolk-shell nanoparticles (YSNPs) are a new class of hollow nanostructures, and their unique properties can be utilized in drug delivery systems. The recent progress in YSNPs-based carriers is highlighted in drug delivery systems. Doxorubicin hydrochloride, ceftriaxone sodium, and methotrexate are three of the most common drugs that are used in this field. According to the reported studies, the materials used most often as yolk-shells are magnetic nanoparticles and polymers. The used methods for synthesizing a diverse array of YSNPs are classified based on their core structures. Various properties of YSNPs include their high drug-loading capacity, and their ability to decrease drug toxicity and satisfactorily and efficiently release drugs. The recent progress in yolk-shell nanoparticles (YSNPs) as a new class of hollow nanostructures applied for drug delivery.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>35518231</pmid><doi>10.1039/d0ra03611k</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-5177-7889</orcidid><orcidid>https://orcid.org/0000-0003-0587-2230</orcidid><orcidid>https://orcid.org/0000-0002-6985-7497</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2046-2069
ispartof RSC advances, 2020-08, Vol.1 (5), p.394-319
issn 2046-2069
2046-2069
language eng
recordid cdi_proquest_miscellaneous_2661081683
source PubMed Central
subjects Chemical Sciences
Chemistry
Doxorubicin
Drug delivery systems
Methotrexate
Nanoparticles
Nanostructure
Toxicity
title Rational design of yolk-shell nanostructures for drug delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T15%3A36%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rational%20design%20of%20yolk-shell%20nanostructures%20for%20drug%20delivery&rft.jtitle=RSC%20advances&rft.au=Mohammadi%20Ziarani,%20Ghodsi&rft.date=2020-08-14&rft.volume=1&rft.issue=5&rft.spage=394&rft.epage=319&rft.pages=394-319&rft.issn=2046-2069&rft.eissn=2046-2069&rft_id=info:doi/10.1039/d0ra03611k&rft_dat=%3Cproquest_cross%3E2435130393%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c554t-3c060ed2a1531aa652651ab7978f18ec163ee214a18fa922a1841cc85d574e0f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2435130393&rft_id=info:pmid/35518231&rfr_iscdi=true